KINDRED BIOSCIENCES, INC. Forms 3, 4 and 5: Other
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 4 rows, 4 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2021-02-09: Reporting owner Lien Lyndon; Form 3; Security No securities beneficially owned.; Transaction Holding.
- 2021-02-09: Reporting owner Liu Nanxi; Form 3/A; Security No securities beneficially owned.; Transaction Holding.
- 2021-02-09: Reporting owner Liu Nanxi; Form 3; Security No securities beneficially owned.; Transaction Holding.
- 2015-01-26: Reporting owner Townsend Raymond; Form 4; Security Common Stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2021-02-09 holding as of filing | Lien Lyndon Director | 3 | No securities beneficially owned. Non-derivative · Direct | Holding | 0 owned after | no price filed | 2021-02-09 | |
| 2021-02-09 holding as of filing | Liu Nanxi Director | 3/A | No securities beneficially owned. Non-derivative · Direct | Holding | 0 owned after | no price filed | 2021-02-09 | |
| 2021-02-09 holding as of filing | Liu Nanxi Director | 3 | No securities beneficially owned. Non-derivative · Direct | Holding | 0 owned after | no price filed | 2021-02-09 | |
| 2015-01-26 | Townsend Raymond Director | 4 | Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +44,000 44,000 owned after | $6.96 exercise price | 2015-01-28 |